October 15, 2018
  • Adverse Event Reporting: When TMI is Risky
  • Brexit Boggles UK Clinical Trials
  • FDA Guidance Clarifies Agency Regulations v. Revised Common Rule

Download PDF Now

October 8, 2018
  • Cancer Trials: Is Progression-Free Survival Enough?
  • Timing is Key in Parkinson’s Clinical Trials

Download PDF Now

October 1, 2018
  • FDA Unveils Guidances on Innovative Trial Design
  • CTTI: New Recommendations for Decentralized Trials
  • Pivotal Clinical Trial Costs Estimated at $19 Million

Download PDF Now

September 24, 2018
  • Sponsors Who Don’t Report Trial Data Face Fines
  • Clinical Trials: There’s an App for That

Download PDF Now

September 17, 2018
  • CNS Drugs Take Longer to Develop, Win Approval
  • Half of EU Clinical Trial Results Not Reported

Download PDF Now

September 10, 2018
  • Ahead on the Science, Behind on the Tech: Clinical Trials Wrestle with AI’s Emergence
  • Final Guidance, Hay Fever, Non-Allergic Rhinitis Trials

Download PDF Now

September 4, 2018
  • Master Protocols Can Kickstart Clinical Trials

  • WCG, Inspire Team Up to Boost Trial Access


Download PDF Now

August 27, 2018
  • Experts Ask FDA to Rethink Trial Exclusion Criteria
  • FDA: New Flexibility for Blinding Cancer Trials

Download PDF Now

August 20, 2018
  • FDA: New Guidance for Expansion Cohort Trials
  • NIH Punts on Basic Brain Research Rules

Download PDF Now

August 13, 2018
  • FDA Seeks $100 Million for Real-World Databank
  • FDA Suggests Endpoints for Opioid Treatments

Download PDF Now